Stephanie O’Malley, Ph.D. is a nationally recognized leader in addiction research. Her work focuses on developing effective pharmacologic and behavioral treatments for substance use disorders, particularly alcohol and tobacco use, through human laboratory paradigms and clinical trials. Dr. O’Malley’s research was pivotal to the FDA approval of naltrexone for alcoholism, and she currently co-leads major NIH-funded centers focused on alcohol and tobacco regulation. She is a former President of the Research Society on Alcoholism and has received numerous awards for her scientific and clinical contributions to the field.